Viewing Study NCT02846766

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2026-02-20 @ 6:05 PM
Study NCT ID: NCT02846766
Status: WITHDRAWN
Last Update Posted: 2018-08-02
First Post: 2016-05-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Lenvatinib in Patients With Advanced Cancer and Aberrations in FGF/FGFR Signaling
Sponsor: Teresa Helsten, MD
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None advanced cancer View
None FGF View
None FGFR View
None Fibroblast Growth Factor Receptor View